Type 1 Diabetes Research for a Cure
The Juvenile Diabetes Research Foundation (JDRF) raises money to drive world-class research into finding a cure for type 1 diabetes and its complications.
Over the last 30 years we have funded more than $US1.3 billion in research and have delivered significant advances. We seek out, assess and monitor the best science worldwide that is working to improve the management of type 1 diabetes and, ultimately to cure type 1 diabetes.
JDRF funded research follows five clearly defined and complementary research pathways.
All funds raised by JDRF worldwide are centralised through JDRF International (based in the USA). This makes sure that global efforts are coordinated for optimum results. Research projects undergo a detailed review by international medical and lay review committees to ensure they contribute to a cure, no matter where they are or what field they are in.
- Professional Advisory Panel judge the scientific merit of the application: the approach, qualifications of the investigator and the relevance to type 1 diabetes
- The Lay Review Panel, which is typically made up of volunteers who have been affected by type 1 diabetes, decides whether a piece of research will ultimately help find a cure and may be rapidly translated into clinical applications
The worldwide nature of our research program actively encourages collaboration, not just between JDRF funded researchers, but with researchers representing other conditions and medical research organisations as well.
To find out about JDRF's latest type 1 diabetes research sign up to our monthly type 1 diabetes newsletter.
You can also find out about our latest developments at the research news section of our website.
You can contribute to type 1 diabetes research
To help JDRF find a cure for type 1 diabetes, you can donate to type 1 diabetes research online. No matter how large or small, your gift will help JDRF continue to move research from the laboratory through to a clinical reality for the 140,000 Australians currently living with type 1 diabetes.
